HomeCHRO • NYSEAMERICAN
add
Chromocell Therapeutics Corp
Previous close
$0.81
Day range
$0.79 - $0.85
Year range
$0.59 - $6.00
Market cap
4.82M USD
Avg Volume
36.69K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.75M | 140.80% |
Net income | -1.77M | -85.83% |
Net profit margin | — | — |
Earnings per share | -0.31 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.41M | 2,836.88% |
Total assets | 2.60M | 3,079.27% |
Total liabilities | 2.79M | -44.08% |
Total equity | -182.52K | — |
Shares outstanding | 5.77M | — |
Price to book | -27.00 | — |
Return on assets | -132.93% | — |
Return on capital | -347.96% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -1.77M | -85.83% |
Cash from operations | -2.95M | -1,424.85% |
Cash from investing | — | — |
Cash from financing | 1.59M | 599.54% |
Net change in cash | -1.37M | -4,201.34% |
Free cash flow | -2.38M | -6,389.39% |
About
Founded
2002
Website
Employees
4